The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
Brief Report
PreviousPrevious
Volume 337:91-95 July 10, 1997 Number 2
NextNext

Effect of Testosterone and Estradiol in a Man with Aromatase Deficiency
Cesare Carani, M.D., Kenan Qin, Ph.D., Manuela Simoni, M.D., Ph.D., Marco Faustini-Fustini, M.D., Stefania Serpente, M.D., Jeff Boyd, Ph.D., Kenneth S. Korach, Ph.D., and Evan R. Simpson, Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Recent reports of disruptive mutations of the genes for the estrogen receptor or for cytochrome P-450 aromatase1,2,3,4,5,6 have shed new light on the role of estrogen. In females the lack of estrogen due to aromatase deficiency leads to pseudohermaphroditism and progressive virilization at puberty, whereas in males pubertal development is normal. In members of both sexes epiphyseal closure is delayed, resulting in a eunuchoid habitus, and osteopenia is present.6 These findings suggest a crucial role of estrogen in skeletal maturation.1,2,3,4,5,6 We describe the responses to androgen and estrogen in a man with a novel, homozygous inactivating mutation of the P-450 . . . [Full Text of this Article]

Case Report

Methods

Biochemical Measurements

Molecular Analysis of the Genes for the Estrogen Receptor and P-450 Aromatase

Discussion


Source Information

From the Department of Internal Medicine, University of Modena, Modena, Italy (C.C., M.F.-F., S.S.); the Cecil and Ida Green Center for Reproductive Biology Sciences and the Departments of Obstetrics–Gynecology and Biochemistry, University of Texas Southwestern Medical Center, Dallas (K.Q., E.R.S.); the Institute of Reproductive Medicine, University of Muenster, Muenster, Germany (M.S.); the Department of Obstetrics and Gynecology, University of Pennsylvania Medical School, Philadelphia (J.B.); and the Laboratory of Reproductive and Developmental Toxicology, National Institutes of Health, Research Triangle Park, N.C. (K.S.K.).

Address reprint requests to Dr. Carani at the Division of Endocrinology, Department of Internal Medicine, University of Modena, Via del Pozzo, 71, I-41100 Modena, Italy.

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.